Regulus Therapeutics Inc. (7RG0.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous close | 1.8600 |
| Open | 1.8500 |
| Bid | 1.5800 x N/A |
| Ask | 1.6500 x N/A |
| Day's range | 1.8500 - 1.8500 |
| 52-week range | 1.0200 - 3.2600 |
| Volume | |
| Avg. volume | 183 |
| Market cap | 123.464M |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Regulus Therapeutics Inc.'s (NASDAQ:RGLS) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week
Key Insights Given the large stake in the stock by institutions, Regulus Therapeutics' stock price might be vulnerable...
- GuruFocus.com
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
Financial and Clinical Progress Amidst Net Loss Wider Than Estimates
- Zacks
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.
© 2024 Yahoo. All rights reserved.